Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Fact-Finding Mission Hydrogen Horizons: Exploring Morocco's Renewable Energy Landscape Jun 09, 2024–Jun 13, 2024
Aktuell Mar 26, 2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
Actualités Nov 03, 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités Oct 19, 2023 Nouveaux fonds pour le traitement de régénération tissulaire de Mimix Biotherapeutics La société biennoise Mimix Biotherapeutics a annoncé la clôture d’un important tour d’investissement, auquel ont participé des investisseurs euro...
Fact Sheet Mar 25, 2024 Market access in France - healthcare sector Our factsheet below provides an overview of the specifics of a reimbursement-based healthcare market, its players, procedures and purchasing chan...
Fact Sheet Mar 12, 2024 Business opportunities: Morocco's 2030 World Cup Morocco's cooperation with Spain & Portugal for the 2030 World Cup is creating huge investment and export opportunities for Swiss and Liechte...
News Oct 19, 2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
Actualités Jan 30, 2024 Les Grands Titres de Suisse occidentale (Janvier 2024) Des avancées révolutionnaires dans l’agroalimentaire et la robotique aux réformes économiques stratégiques en passant par la recherche pionnière ...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
Aktuell Jan 19, 2024 Wunden sollen durch Löten verschlossen werden Forschende der Empa haben in Zusammenarbeit mit der Eidgenössischen Technischen Hochschule Zürich eine neue Methode des Wundverschlusses entwicke...
News Apr 30, 2024 Guy Parmelin opens Park Innovaare Switzerland Innovation Park Innovaare has officially been opened. The innovation park located adjacent to the Paul Scherrer Institute becomes the...
News Apr 30, 2024 Ivoclar and SkyCell join forces to avoid dead freight from the USA Ivoclar and SkyCell are optimizing reverse logistics. The dental company now ships its products that have been manufactured in the USA and destin...
News Apr 19, 2024 2HS AG launches platform for graphene products 2HS AG has launched the one-graphene platform, where the startup specializing in graphene nanoelectrics offers synthetic single-crystalline CVD g...
Aktuell Jan 09, 2024 Molecular Partners und Orano Med kooperieren Molecular Partners und Orano Med werden in der Entwicklung von Proteinmedikamenten, sogenannten DARPin-Therapeutika, zusammenarbeiten. Deren radi...
Actualités Jan 30, 2023 Alithea Genomics et le CHUV vont aider à rendre les traitements d’immunothérapie plus ciblés Le consortium néerlando-suisse MAINLINE, composé de PamGene International B.V., d'Alithea Genomics et du CHUV, a reçu une subvention Eurostars de...